While activating mutations in FLT3 are relatively rare in infants suffering from ALL, the overexpression of wild-type FLT3, causing autoactivation, is a notable characteristic and high-risk factor in KMT2A-r leukemias [68]. The gene discussed is FLT3; the disease is leukemia.